Article Text

Download PDFPDF
Letter
Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus—authors' response

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors YR and AJS wrote the text jointly.

  • Funding National Institute of Diabetes and Digestive and Kidney Diseases (Intramural Research Program).

  • Competing interests AS: Consultant for Echosens-Sandhil and Sequana.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles